Scott Michael Lindhorst

Scott Michael Lindhorst, MD, is an Assistant Professor in the Department of Neurosurgery at the Medical University of South Carolina (MUSC) College of Medicine. He holds a dual appointment in the Division of Hematology/Medical Oncology within the Department of Medicine. Dr. Lindhorst specializes in neuro-oncology, focusing on central nervous system lymphomas, gliomas, and meningiomas, while also managing brain metastases through clinical trials.

• Education: BS in Microbiology from University of Florida (2001), MD from University of South Alabama College of Medicine (2005)
• Training: Residency in Internal Medicine, Fellowship in Hematology/Medical Oncology (University of Alabama at Birmingham), Fellowship in Neuro-Oncology (Duke University Medical Center)

His research centers on immuno-oncology, glioblastoma therapy, and epigenetic cancer treatments, with a strong emphasis on clinical trials for novel therapies. Recent publications explore hypermutation in cancer, immune checkpoint inhibition, and programmed necrosis in glioblastoma. Dr. Lindhorst is board-certified in internal medicine, hematology, medical oncology, and neuro-oncology.

Clinical practice includes CNS lymphomas, gliomas, meningiomas, and brain metastases, with dedicated clinical trials to advance treatment options.